Adding L-citrulline increases plasma L-arginine in men

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

Reference Suzuki T, Morita M, Hayashi T, Kamimura A. The effects of combined oral L-citrulline and L-arginine supplementation in healthy men on plasma L-arginine levels. Biosci Biotechnol Biochem. 2017;81(2):372-375. Design Double-blind, randomized, placebo-controlled trial Participants 42 healthy, non-obese Japanese men aged 20-49; Smokers and men taking medications or dietary supplements were excluded. Men were randomized into 1 of 4 groups: Placebo (cornstarch) (n = 11) L-citrulline alone 2.0 g/day (n = 11) L-arginine alone 2.0 g/day (n = 10) L-citrulline with L-arginine, 1.0 g/day each (n = 10) Primary outcome measure Plasma levels of L-arginine after supplementation Key findings One …

Bezug Suzuki T, Morita M, Hayashi T, Kamimura A. Die Auswirkungen einer kombinierten oralen L-Citrullin- und L-Arginin-Supplementierung bei gesunden Männern auf die Plasma-L-Arginin-Spiegel. Biosci Biotechnol Biochem. 2017;81(2):372-375. Entwurf Doppelblinde, randomisierte, Placebo-kontrollierte Studie Teilnehmer 42 gesunde, nicht übergewichtige japanische Männer im Alter von 20-49; Raucher und Männer, die Medikamente oder Nahrungsergänzungsmittel einnahmen, wurden ausgeschlossen. Die Männer wurden in 1 von 4 Gruppen randomisiert: Placebo (Maisstärke) (n = 11) L-Citrullin allein 2,0 g/Tag (n = 11) L-Arginin allein 2,0 g/Tag (n = 10) L-Citrullin mit L-Arginin, jeweils 1,0 g/Tag (n = 10) Primäre Ergebnismessung Plasmaspiegel von L-Arginin nach Supplementierung Wichtige Erkenntnisse Eine …
Reference Suzuki T, Morita M, Hayashi T, Kamimura A. The effects of combined oral L-citrulline and L-arginine supplementation in healthy men on plasma L-arginine levels. Biosci Biotechnol Biochem. 2017;81(2):372-375. Design Double-blind, randomized, placebo-controlled trial Participants 42 healthy, non-obese Japanese men aged 20-49; Smokers and men taking medications or dietary supplements were excluded. Men were randomized into 1 of 4 groups: Placebo (cornstarch) (n = 11) L-citrulline alone 2.0 g/day (n = 11) L-arginine alone 2.0 g/day (n = 10) L-citrulline with L-arginine, 1.0 g/day each (n = 10) Primary outcome measure Plasma levels of L-arginine after supplementation Key findings One …

Adding L-citrulline increases plasma L-arginine in men

Relation

Suzuki T, Morita M, Hayashi T, Kamimura A. The effects of combined oral L-citrulline and L-arginine supplementation in healthy men on plasma L-arginine levels.Biosci Biotechnol Biochem. 2017;81(2):372-375.

Draft

Double-blind, randomized, placebo-controlled study

Participant

42 healthy, non-obese Japanese men aged 20-49; Smokers and men taking medications or dietary supplements were excluded. The men were randomized into 1 of 4 groups:

  1. Placebo (Maisstärke) (n = 11)
  2. L-Citrullin allein 2,0 g/Tag (n = 11)
  3. L-Arginin allein 2,0 g/Tag (n = 10)
  4. L-Citrullin mit L-Arginin, jeweils 1,0 g/Tag (n = 10)

Primary outcome measure

Plasma levels of L-arginine after supplementation

Key insights

One hour after supplementation, all groups had an increase in L-arginine plasma levels compared to placebo; however, values ​​were significantly higher in the L-citrulline, L-arginine combination group (placebo 5.4 ± 16.3; combination 121.9 ± 46.7; citrulline alone 66.3 ± 33.6; arginine alone 72.3 ± 31.5). Levels in the combination group were approximately 40% higher than in the L-arginine alone group. None of the participants experienced side effects from any of the treatments during the study.

Practice implications

While previous animal studies have shown that combining L-arginine with L-citrulline increases L-arginine plasma levels, to my knowledge this is the first human clinical study to show this effect.1.2This is clinically significant given the research showing the diverse and important health benefits of L-arginine supplementation in men. Human clinical studies have shown that L-arginine supplementation can help improve erectile dysfunction (ED).3insulin resistance,4and sporting performance.5

Specific to ED, research shows that men with ED have low serum levels of L-citrulline and L-arginine.6Reduced nitric oxide levels are associated with an increased risk of erectile dysfunction. Arginine is a nitric oxide precursor, so it makes sense that low concentrations of nitric oxide synthase substrates such as L-arginine and L-citrulline could positively impact ED.

This is clinically significant given the research showing the diverse and important health benefits of L-arginine supplementation in men.

There is also evidence that supplemental L-arginine may help prevent and treat cardiovascular disease, likely due to its influence on endothelial nitric oxide production.7.8A review by Alyavi et al. from 2016 demonstrated the clinical benefit of L-arginine supplementation specifically in ischemic heart disease and again cited synthesis of nitric oxide production as a key mechanism of action.9

Based on previous in vitro and in vivo research showing that L-citrulline suppresses arginase activity,10The researchers of this present study speculate that this could be a possible mechanism that explains the significant increase with the combination of the 2 amino acids. Previous research has shown that oral L-arginine has reduced bioavailability as it is broken down by arginase in the gastrointestinal tract (40%) and liver (15%) on the first pass.11,12In the past, fairly large doses of L-arginine alone were required to produce a therapeutic effect in humans. By inhibiting arginase activity through the addition of L-citrulline, it is likely that more L-arginine can pass through the intestines and liver into the bloodstream. As shown in this study and previous studies, L-citrulline is a precursor to L-arginine and alone can increase L-arginine levels.13

Since we know that L-arginine can positively impact a man's health, it makes sense from a clinical perspective to investigate this combination as it appears to improve the bioavailability of an oral L-arginine supplement. Since this was a small study, further research is needed to further confirm this effect.

  1. Hayashi T, Juliet PA, Matsui-Hirai H, et al. Eine L-Citrullin- und L-Arginin-Supplementierung verzögert das Fortschreiten der durch eine cholesterinreiche Ernährung verursachten Atherosklerose bei Kaninchen. Proc Natl Acad Sci USA. 2005;102(38):13681-13686.
  2. Morita M., Hayashi T., Ochiai M. et al. Die orale Supplementierung mit einer Kombination aus L-Citrullin und L-Arginin erhöht schnell die Plasma-L-Arginin-Konzentration und verbessert die Bioverfügbarkeit von NO. Biochem Biophys Res Commun. 2014;454(1):53-57.
  3. Chen J, Wollman Y, Chernichovsky T, Iaina A, Sofer M, Matzkin H. Wirkung der oralen Verabreichung von hochdosiertem Stickoxid-Donator L-Arginin bei Männern mit organischer erektiler Dysfunktion: Ergebnisse einer doppelblinden, randomisierten Placebo- kontrolliertes Studium. BJU Int. 1999;83(3):269-273.
  4. Bogdanski P, Suliburska J, Grabanska K, Jablecka A. Wirkung einer 3-monatigen L-Arginin-Supplementierung auf die Insulinresistenz und die Aktivität des Tumornekrosefaktors bei Patienten mit viszeraler Adipositas. Eur. Rev. Med. Pharmacol. Sci. 2012;16:816-823.
  5. Koppo K, Taes YE, Pottier A, Boone J, Bouckaert T, Derave W. Nahrungsergänzung mit Arginin beschleunigt die pulmonale VO2-Kinetik während des Fahrradtrainings. Med Sci Sport Exerc. 2009;41(8):1626-1632.
  6. Barassi A, Corsi Romanelli MM, Pezzilli R, et al. Spiegel von L-Arginin und L-Citrullin bei Patienten mit erektiler Dysfunktion unterschiedlicher Ätiologie. Andrologie. 2017;5(2):256-261.
  7. Tousoulis D, Antoniades C, Tentolouris C, et al. L-Arginin bei Herz-Kreislauf-Erkrankungen: Traum oder Realität. Vasc Med. 2002;7(3):203-211.
  8. Bahadoran Z, Mirmiran P, Tahmasebinejad Z, Azizi F. Nahrungsaufnahme von L-Arginin und das Auftreten von koronarer Herzkrankheit: Lipid- und Glukosestudie in Teheran. Nutr Metabol. 2016;13:23.
  9. Alyavi AL, Alyavi BA, Sayfiyev NY, et al. Klinischer Nutzen der metabolischen Therapie der ischämischen Herzkrankheit mit L-Arginin-Supplementierung. Saudi J. Med. Pharm. Sci. 2016;2(9):247-249.
  10. Romero MJ, Platt DH, Tawfik HE, et al. Diabetes-induzierte koronare vaskuläre Dysfunktion beinhaltete Arginase-Aktivität. Circ Res. 2008;102(1):95-102.
  11. Wu G. Aminosäurekatabolismus der Darmschleimhaut. J Nutr. 1998;128(8):1249-1252.
  12. O’Sullivan D, Brosnan JT, Brosnan ME. Hepatische Zonierung des Katabolismus von Arginin und Ornithin in der perfundierten Rattenleber. Biochemie J. 1998;330(Teil 2):627-632.
  13. Schwedhelm E, Maas R, Freese R, et al. Pharmakokinetische und pharmakodynamische Eigenschaften von oralem L-Citrullin und L-Arginin: Auswirkungen auf den Stickoxidstoffwechsel. Br J Clin Pharmacol. 2008;65(1):51-59.